The Expansion Dilemma of GreenPath Solutions Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics:

Revenue: $42M (FY2023), 12% YoY growth.
EBITDA Margin: 14% (down from 18% in 2021).
Customer Acquisition Cost (CAC): Increased from $450 to $720 over 24 months.
Liquidity: $8M cash on hand; $15M debt facility available at 8.5% interest.

Operational Facts:

Capacity: Current facility operates at 88% utilization.
Geography: 95% of revenue concentrated in the Pacific Northwest.
Supply Chain: Reliance on three key suppliers for raw polymers.

Stakeholder Positions:

CEO (Marcus Thorne): Favors aggressive expansion into the East Coast market.
CFO (Elena Rodriguez): Advocates for margin stabilization and debt reduction before expansion.
Board: Concerned with the declining EBITDA margin and increasing CAC.

Information Gaps:

Specific East Coast market penetration costs are estimated, not verified.
Competitor pricing data for the East Coast is absent.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

Should GreenPath prioritize geographic expansion to the East Coast or focus on margin improvement within the current footprint?

Structural Analysis

Five Forces: Buyer power is high due to low switching costs. Competitive rivalry is intense; existing players have scale advantages that GreenPath lacks.
Value Chain: The current CAC trajectory suggests the saturation of the Pacific Northwest market. Operational efficiency is hindered by high raw material costs.

Strategic Options

Option A: East Coast Expansion. Rationale: Capture market share in a higher-density region. Trade-offs: Dilution of cash reserves, increased operational complexity. Requirements: $12M capital expenditure.
Option B: Operational Optimization. Rationale: Improve EBITDA by renegotiating supplier contracts and automating production. Trade-offs: Limited top-line growth. Requirements: $3M investment.

Preliminary Recommendation

Pursue Option B for 12 months to restore EBITDA margins to 18% before initiating a phased entry into the East Coast. Scaling a low-margin business is a path to insolvency.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

Month 1-3: Supplier renegotiation and consolidation of raw material sourcing.
Month 4-8: Facility automation to reduce labor-per-unit costs.
Month 9-12: Performance audit to determine if the 18% margin target is met.

Key Constraints

Supplier lock-in: Current contracts expire in 14 months.
Talent: Lack of internal expertise in automated manufacturing.

Risk-Adjusted Strategy

Maintain the $8M cash buffer. If margin targets are missed by month 6, pivot to a licensing model for the East Coast rather than full operational entry.

4. Executive Review and BLUF (Executive Critic)

BLUF

GreenPath is bleeding cash through inefficient customer acquisition and rising operational costs. Expanding into the East Coast now is a mistake that will accelerate the current liquidity decline. The company must stabilize its core operations first. Reject the CEO’s expansion plan. Implement the CFO’s focus on margin recovery for 12 months. If the EBITDA margin does not return to 18% by the end of this period, the company should explore a strategic sale or a licensing-only model for new markets rather than capital-intensive expansion.

Dangerous Assumption

The assumption that the East Coast market will respond to the same value proposition as the Pacific Northwest without a significantly higher CAC is unsupported by the current data.

Unaddressed Risks

Competitive Reaction: Larger incumbents may initiate a price war if GreenPath attempts to enter the East Coast.
Supply Chain Volatility: Relying on three suppliers for 100% of inputs leaves the firm vulnerable to price shocks that will destroy the proposed margin recovery.

Unconsidered Alternative

Strategic partnership with an established East Coast distributor. This allows for market presence without the heavy capital expenditure of building a new operational footprint.